Hrs-aki

Portal hypertension promotes vasodilation within the splanchnic circulation, the blood-vessel network supplying abdominal organs. This redistribution lowers effective arterial blood volume even when total body fluid is not described as depleted. The circulation then activates the sympathetic nervous system and the renin-angiotensin-aldosterone system, producing compensatory responses that ultimately reduce renal perfusion.

These responses cause renal vasoconstriction, narrowing the blood vessels that supply the kidneys. Reduced renal perfusion lowers kidney function despite the absence of primary structural injury. This hemodynamic mechanism helps explain why the decline can be potentially reversible and why clinicians must assess circulatory context rather than interpret kidney dysfunction in isolation.

HRS-AKI is considered only after other causes of kidney injury have been excluded. The absence of primary structural injury supports a functional, circulation-related explanation, but it does not establish the diagnosis by itself. Clinicians therefore combine the kidney-function change with the patient’s advanced liver disease, cirrhosis, and overall clinical context.

Assessment combines an acute change in serum creatinine with the setting of advanced liver disease or cirrhosis and a search for alternative causes of kidney injury. No single finding is sufficient on its own. This combined approach links the timing of kidney dysfunction to the relevant clinical context while supporting exclusion-based diagnostic reasoning.

Recognition identifies a clinical situation in which albumin and vasoconstrictors may be used as treatment options. The diagnosis therefore does more than label a change in kidney function; it connects the patient’s hemodynamic problem with targeted management decisions. Establishing the diagnosis can also help clinicians organize further monitoring and escalation of care.

Early recognition can accelerate several time-sensitive clinical decisions. It supports treatment with albumin and vasoconstrictors, guides decisions about intensive monitoring, and can hasten referral for liver transplantation. Because the kidney decline may be potentially reversible, identifying the syndrome promptly is clinically important for coordinating management in advanced liver disease.